Literature DB >> 26070583

Device Cleaning and Infection Control in Aerosol Therapy.

Catherine A O'Malley1.   

Abstract

Aerosol delivery equipment used to administer inhaled medications includes the nebulizer, positive expiratory pressure devices added to the nebulizer, and valved holding chambers (spacers). These devices are semi-critical medical devices, and as such, infection prevention and control (IPC) guidelines recommend that they be cleaned, disinfected, rinsed with sterile water, and air-dried. There is confusion surrounding the care of aerosol devices because of inconsistencies in the various published IPC guidelines, lack of a standard of practice among institutions and respiratory therapists (RTs), and manufacturer's instructions for use of these devices are not always compatible with guidelines or practice. Challenges lie in awareness of IPC guidelines and establishing a standard for the care of aerosol delivery devices among all stakeholders/manufacturers, governments, vendors, and users. The latest IPC guideline from the Cystic Fibrosis Foundation, reviewed and endorsed by the Society for Healthcare Epidemiology of America and the Association for Professionals in Infection Control, has a recommendation for disposable nebulizers and a recommendation for reusable nebulizers. Reusable nebulizers should be cleaned, disinfected, rinsed with sterile water (if using a cold disinfectant), and air-dried between uses. The mouthpiece/mask of disposable nebulizers should be wiped with an alcohol pad, the residual volume should be rinsed out with sterile water after use, and the nebulizer should be replaced every 24 h. The RT plays a significant and responsible role in providing and teaching aerosol therapy to patients. The RT and all stakeholders need to work together to provide a standard of care for the safe use of aerosol delivery devices.
Copyright © 2015 by Daedalus Enterprises.

Entities:  

Keywords:  aerosol drug therapy; equipment contamination; infection control; infection prevention; inhalation spacers; inhalers; medical devices; nebulizers; respiratory therapy; valved holding chambers

Mesh:

Substances:

Year:  2015        PMID: 26070583     DOI: 10.4187/respcare.03513

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  11 in total

Review 1.  Nebuliser hygiene in cystic fibrosis: evidence-based recommendations.

Authors:  Jane Bell; Lauren Alexander; Jane Carson; Amanda Crossan; John McCaughan; Hazel Mills; Damian O'Neill; John E Moore; B Cherie Millar
Journal:  Breathe (Sheff)       Date:  2020-06

2.  A short-term evaluation of a prototype disposable Oscillating Positive Expiratory Pressure (OPEP) device in a cohort of children with cystic fibrosis.

Authors:  Kevin J O'Sullivan; Valerie Power; Barry Linnane; Deirdre McGrath; Magdalena Mulligan; Rebecca White; Leonard W O'Sullivan; Colum P Dunne
Journal:  BMC Pulm Med       Date:  2021-05-12       Impact factor: 3.317

Review 3.  Spacer devices for inhaled therapy: why use them, and how?

Authors:  Walter Vincken; Mark L Levy; Jane Scullion; Omar S Usmani; P N Richard Dekhuijzen; Chris J Corrigan
Journal:  ERJ Open Res       Date:  2018-06-18

Review 4.  Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems.

Authors:  Ahmed A H Abdellatif; Hesham M Tawfeek; Ahmed Abdelfattah; Gaber El-Saber Batiha; Helal F Hetta
Journal:  J Drug Deliv Sci Technol       Date:  2021-02-19       Impact factor: 3.981

Review 5.  Nasally inhaled therapeutics and vaccination for COVID-19: Developments and challenges.

Authors:  Jinxiang Xi; Lameng Ray Lei; William Zouzas; Xiuhua April Si
Journal:  MedComm (2020)       Date:  2021-12-14

6.  Assessment of the microbial load of airway clearance devices used by a cohort of children with cystic fibrosis.

Authors:  B Linnane; N H O'Connell; E Obande; S S Dunne; C Clancy; M G Kiernan; D McGrath; K J O'Sullivan; L O'Sullivan; C P Dunne
Journal:  Infect Prev Pract       Date:  2021-06-06

7.  An initial evaluation of the safety of a disposable oscillating positive expiratory pressure device in patients with chronic obstructive pulmonary disease: a sort-term pilot study.

Authors:  Kevin J O'Sullivan; Valerie Power; Barry Linnane; Deirdre McGrath; Hilda Fogarty; Martina Ryan; Rebecca White; Conor Noonan; Eithne Mulloy; Leonard W O'Sullivan; Colum P Dunne
Journal:  BMC Pulm Med       Date:  2021-10-19       Impact factor: 3.317

8.  Cleaning and infection control of airway clearance devices used by CF patients.

Authors:  Eynav Manor; Michal Gur; Yuval Geffen; Lea Bentur
Journal:  Chron Respir Dis       Date:  2017-05-17       Impact factor: 2.444

Review 9.  Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19.

Authors:  Arzu Ari
Journal:  Respir Med       Date:  2020-04-21       Impact factor: 4.582

Review 10.  Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2.

Authors:  Rajiv Dhand; Jie Li
Journal:  Am J Respir Crit Care Med       Date:  2020-09-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.